Evolving Frontline Treatments for Patients With Newly Diagnosed Multiple Myeloma: Quadruplet Regimens Show PromiseByIssam S. Hamadeh, PharmD, BCPS, BCOP,Shebli Atrash, MD,Carlyn Rose Tan, MDJuly 18th 2024IMROZ study data show Isa-VRd may be a new standard of care.